
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cortex Pharmaceuticals, | AMEX:COR | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
RNS Number:9659S Chorion PLC 07 December 2003 8 December 2003 Response to press speculation The Board of Chorion PLC ("Chorion") has noted the story carried in The Sunday Times concerning an approach made to it by Entertainment Rights plc. The Board confirms that it has recently received an unsolicited and indicative approach from Entertainment Rights plc. This is the latest in a long series of unsolicited and unwelcome approaches, commencing some 3 years ago, none of which has resulted in an offer being made for Chorion by Entertainment Rights plc. The Board of Chorion, having consulted its financial advisors, has rejected this latest approach as it significantly undervalues Chorion. Enquiries please call: Tim Allan Portland, for Chorion 020 7404 5344 This information is provided by RNS The company news service from the London Stock Exchange END RSPTRBTTMMBMTBJ
1 Year Cortex Pharm Chart |
1 Month Cortex Pharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions